Creo Medical Group PLC (LON:CREO) Insider Buys £699,999.84 in Stock

Creo Medical Group PLC (LON:CREO) insider Kevin Crofton bought 2,916,666 shares of the firm’s stock in a transaction that occurred on Monday, October 21st. The stock was bought at an average cost of GBX 24 ($0.31) per share, for a total transaction of £699,999.84 ($908,854.64).

Creo Medical Group Price Performance

Creo Medical Group stock opened at GBX 20.25 ($0.26) on Thursday. The firm has a fifty day moving average of GBX 26.46 and a 200-day moving average of GBX 31.33. The firm has a market capitalization of £73.26 million, a P/E ratio of -334.80 and a beta of 0.86. Creo Medical Group PLC has a 52-week low of GBX 19.86 ($0.26) and a 52-week high of GBX 50 ($0.65). The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.